Application 018152
- Type
- NDA
- Sponsor
- JDS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ESKALITH CR | LITHIUM CARBONATE | TABLET, EXTENDED RELEASE;ORAL | 450MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | No | No |